The distant failure rate (25.8% vs 45.8%) between 2 groups did not reach statistical significance.
← all excerpts
Dose-escalated radiotherapy improved survival for esophageal cancer patients with a clinical complete response after standard-dose radiotherapy with concurrent chemotherapy.
1
—
—